Commonwealth Equity Services, LLC Sangamo Therapeutics, Inc Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 68,148 shares of SGMO stock, worth $139,703. This represents 0.0% of its overall portfolio holdings.

Number of Shares

68,148

Previous 59,748 14.06%

Holding current value

$139,703

Previous $21,000 180.95%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$0.32 - $1.1 $2,688 - $9,240	8,400 Added 14.06%	68,148 $59,000
Q2 2024 Jul 31, 2024	SELL	$0.36 - $0.65 $73 - $132	-204 Reduced 0.34%	59,748 $21,000
Q1 2024 Apr 29, 2024	BUY	$0.42 - $1.38 $11,887 - $39,059	28,304 Added 89.43%	59,952 $40,000
Q4 2023 Feb 06, 2024	SELL	$0.3 - $0.63 $5,594 - $11,748	-18,648 Reduced 37.08%	31,648 $17,000
Q3 2023 Oct 23, 2023	BUY	$0.58 - $1.47 $2,572 - $6,520	4,436 Added 9.67%	50,296 $30,000
Q2 2023 Aug 10, 2023	BUY	$1.11 - $1.74 $20,973 - $32,877	18,895 Added 70.07%	45,860 $60,000
Q1 2023 May 11, 2023	BUY	$1.66 - $3.67 $642 - $1,420	387 Added 1.46%	26,965 $47,000
Q4 2022 Feb 07, 2023	BUY	$2.77 - $5.07 $7,628 - $13,962	2,754 Added 11.56%	26,578 $83,000
Q2 2022 Jul 19, 2022	BUY	$3.28 - $6.21 $2,683 - $5,079	818 Added 3.56%	23,824 $98,000
Q1 2022 May 04, 2022	SELL	$5.23 - $7.82 $46,097 - $68,925	-8,814 Reduced 27.7%	23,006 $133,000
Q4 2021 Jan 31, 2022	SELL	$7.29 - $10.97 $8,879 - $13,361	-1,218 Reduced 3.69%	31,820 $238,000
Q3 2021 Oct 29, 2021	SELL	$9.01 - $12.01 $21,542 - $28,715	-2,391 Reduced 6.75%	33,038 $297,000
Q2 2021 Aug 11, 2021	SELL	$10.17 - $12.64 $11,187 - $13,904	-1,100 Reduced 3.01%	35,429 $424,000
Q1 2021 May 04, 2021	BUY	$10.88 - $17.05 $168,792 - $264,513	15,514 Added 73.82%	36,529 $457,000
Q4 2020 Feb 11, 2021	SELL	$9.23 - $18.18 $12,109 - $23,852	-1,312 Reduced 5.88%	21,015 $327,000
Q3 2020 Nov 05, 2020	SELL	$9.38 - $12.48 $9,380 - $12,480	-1,000 Reduced 4.29%	22,327 $210,000
Q2 2020 Aug 12, 2020	BUY	$6.21 - $11.83 $41,526 - $79,107	6,687 Added 40.19%	23,327 $209,000
Q1 2020 May 11, 2020	SELL	$5.05 - $8.85 $48,843 - $85,597	-9,672 Reduced 36.76%	16,640 $106,000
Q4 2019 Feb 05, 2020	BUY	$8.03 - $11.7 $89,285 - $130,092	11,119 Added 73.19%	26,312 $220,000
Q3 2019 Oct 30, 2019	BUY	$9.05 - $12.22 $6,135 - $8,285	678 Added 4.67%	15,193 $137,000
Q2 2019 Jul 19, 2019	SELL	$8.75 - $13.03 $9,458 - $14,085	-1,081 Reduced 6.93%	14,515 $156,000
Q1 2019 May 13, 2019	SELL	$7.72 - $12.81 $91,281 - $151,465	-11,824 Reduced 43.12%	15,596 $148,000
Q4 2018 Feb 11, 2019	SELL	$9.51 - $16.6 $3,784 - $6,606	-398 Reduced 1.43%	27,420 $314,000
Q3 2018 Nov 06, 2018	BUY	$13.05 - $19.05 $132,914 - $194,024	10,185 Added 57.76%	27,818 $471,000
Q2 2018 Jul 31, 2018	BUY	$13.9 - $19.8 $34,013 - $48,450	2,447 Added 16.11%	17,633 $250,000
Q1 2018 May 14, 2018	BUY	$16.7 - $26.35 $253,606 - $400,151	15,186 New	15,186 $288,000

Others Institutions Holding SGMO

# of Institutions

114

Shares Held

56.3M

Call Options Held

576K

Put Options Held

1.17M

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $321M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Sangamo Therapeutics, Inc Transaction History